4//SEC Filing
Chaturvedi Pravin R 4
Accession 0001104659-24-048347
CIK 0001585608other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:33 PM ET
Size
8.2 KB
Accession
0001104659-24-048347
Insider Transaction Report
Form 4
Chaturvedi Pravin R
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-04-05+134→ 1,270 total - Award
Restricted stock units
2024-04-05−134→ 0 total→ Common Stock (134 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "September 2021 Reverse Stock Split"). Upon effectiveness of the September 2021 Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
- [F3]The restricted stock units were previously reported as covering 30,000 shares, but were adjusted to reflect the September 2021 Reverse Stock Split and January 2023 Reverse Stock Split. Such restricted stock units were granted on April 5, 2021 and vest in three equal annual installments beginning on April 5, 2022, the first anniversary of the grant date.
Documents
Issuer
Jaguar Health, Inc.
CIK 0001585608
Entity typeother
Related Parties
1- filerCIK 0001916935
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:33 PM ET
- Size
- 8.2 KB